Total Nilai Perusahaan: Citius Oncology, Inc. (CTOR)
This chart of the market valuation for Citius Oncology, Inc. (CTOR) on the GURU.Markets platform, which stands at 47.28, is based on expectations for future sales of T-cell lymphoma drugs. Current growth is driven by preparations to launch a new skin therapy agent. Meanwhile, the business relies on exclusive FDA rights, which ensure the protection of a niche segment from low-cost generics.
Ringkesan rincian data analitis Citius Oncology, Inc. (CTOR)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi bursa perusahaan:
- data kapitalisasi buku:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Citius Oncology, Inc.|CTOR - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang modal citiusonc.com|CTOR - Gunggung utang perusahaan|Utang marang nilai buku Citius Oncology|CTOR - Utang jangka dawa perusahaan|Utang jangka cendhak Citius Oncology|Rasio jangkoan perantara citiusonc.com
- statistik bathi lan rasio pasar:
Ringkesan analitik perusahaan:CTOR - Citius Oncology Inc.
Enterprise Value (EV) represents the total buyout price of an asset, combining market capitalization with net debt to determine the actual cost of acquiring a business. Analyzing changes in EV levels allows an investor to promptly identify an overvaluation of Citius Oncology, Inc. (CTOR), whose value depends directly on market confidence in innovative targeted therapies for rare lymphomas.
Karo sapa Citius Oncology, Inc. saingan
Total Nilai Bisnis ONC (BeiGene Ltd.)|HALO - Nilai Total Perusahaan|Total Nilai Perusahaan Revolution Medicines Corp|Ascentage Pharma Group (AAPG) - Nilai Total Perusahaan|cgoncology.com - Nilai Dipunlarasaken Utang lan Kas|URGN (UroGen Pharma) - Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Bicara Therapeutics Inc (BCAX)|Nilai Perusahaan PSNL|Nilai Perusahaan Erasca Oncology (ERAS)|Nilai Total Perusahaan Delcath Systems, Inc. DCTH|YMAB: Nilai Bisnis|Aura Biosciences - Nilai Perusahaan|Candel Therapeutics (CADL) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|ARAY: Nilai Perusahaan|Total Nilai Perusahaan SELLAS Life Sciences Group (SLS)|Nilai Total Perusahaan Actuate Therapeutics, Inc.|HURA: Nilai Dipunlarasaken Utang lan Kas|Rega Nyata Tumbas Perusahaan Kanthi Wutuh TARA (Protara Therapeutics, Inc.)|FATE (Fate Therapeutics Inc) - Nilai Dipunlarasaken Utang lan Kas|Nilai Perusahaan WHWK (Aadi Bioscience)|TCRX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|CSBR: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|XBIT - Nilai Perusahaan|cel-sci.com (CVM) - Nilai Total Perusahaan|OS Therapies Inc. - Nilai Dipunlarasaken Utang lan Kas|RADX (Radiopharm Theranostics) - Nilai Perusahaan|Total Nilai Perusahaan Artiva ARTV|Nilai Perusahaan ANL|Rega Nyata Tumbas Perusahaan Kanthi Wutuh verupharma.com VERU|Nilai Perusahaan TPST (Tempest Therapeutics, Inc.)|Rega Tumbas Perusahaan Xilio Therapeutics Inc (XLO)|RENB: Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Mural Oncology plc - Total Nilai Bisnis|KAPA: Nilai Perusahaan|OKUR - Rega Tumbas Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh GDTC|Nilai Perusahaan Curis Corp|Nilai Total Perusahaan Apollomics, Inc. (APLM)|Rega Tumbas Perusahaan Tharimmune Corporation|Advanced Biomed - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Dipunlarasaken Utang lan Kas GNPX|CLDI - Nilai Total Perusahaan|Total Nilai Perusahaan sunshinebiopharma.com|xeneticbio.com (XBIO) - Nilai Total Perusahaan|Nilai Bisnis SLRX|PPBT (Purple Biotech) - Nilai Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh AON (AONC)|Nilai Total Perusahaan BeiGene (BGNE)|CKPT - Total Nilai Perusahaan|Nilai Total Perusahaan Elevation Oncology ELEV|iCAD Inc. - Nilai Total Perusahaan|IKNA - Nilai Total Perusahaan|Total Nilai Perusahaan notablelabs.com|VIRX: Nilai Perusahaan|Nilai Perusahaan Nalika Diakuisisi Penuh MorphoSys Inc MOR|Rega Nyata Tumbas Perusahaan Kanthi Wutuh NAYA|Total Nilai Perusahaan Ascentage AAPGV